Literature DB >> 25472889

[Methodology of the development of the updated LONTS guidelines for long-term administration of opioids in noncancer pain].

W Häuser1, P Klose, P Welsch, F Petzke, M Nothacker, I Kopp.   

Abstract

BACKGROUND: The update of the German S3 guidelines on long-term opioid therapy of chronic noncancer pain (CNCP), the"LONTS" (AWMF registration number 145/003) was scheduled for May 2014.
METHODS: The guidelines were developed by 25 scientific societies and two patient self-help organizations under the coordination of the German Pain Society and the Association of the Scientific Medical Societies in Germany (AWMF).
RESULTS: A systematic literature search was performed in the CENTRAL, MEDLINE and Scopus databases from October 2008 to October 2013. Meta-analyses of randomized controlled trials (RCT) of opioids in CNPC of study duration ≥ 4 weeks were conducted. Levels of evidence were assigned according to the Oxford Centre for Evidence-Based Medicine version 2009 classification system. The formulation and strength of recommendations was established in a multistep formalized consensus procedure, in accordance with AWFM rules and standards. The guidelines were reviewed by three scientific societies not involved in their development and were approved by the executive boards of the societies that were engaged in development of the guidelines.
CONCLUSION: The guidelines will be published in several forms: complete and short scientific versions, as well as clinical practice and patient versions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25472889     DOI: 10.1007/s00482-014-1462-y

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  22 in total

1.  [Methodological basis for the development of consensus recommendations].

Authors:  J C Hoffmann; I Fischer; W Höhne; M Zeitz; H-K Selbmann
Journal:  Z Gastroenterol       Date:  2004-09       Impact factor: 2.000

Review 2.  Opioids for chronic noncancer pain: a new Canadian practice guideline.

Authors:  Andrea D Furlan; Rhoda Reardon; Clarence Weppler
Journal:  CMAJ       Date:  2010-05-03       Impact factor: 8.262

Review 3.  "Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews.

Authors:  Andrew R Moore; Christopher Eccleston; Sheena Derry; Phillip Wiffen; Rae F Bell; Sebastian Straube; Henry McQuay
Journal:  Pain       Date:  2010-06-02       Impact factor: 6.961

Review 4.  Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain.

Authors:  Teryl K Nuckols; Laura Anderson; Ioana Popescu; Allison L Diamant; Brian Doyle; Paul Di Capua; Roger Chou
Journal:  Ann Intern Med       Date:  2014-01-07       Impact factor: 25.391

5.  [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].

Authors:  U Marschall; B Arnold; W Häuser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

Review 6.  [Opioids in chronic noncancer pain-are opioids superior to nonopioid analgesics? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids versus nonopioid analgesics of at least four week's duration].

Authors:  P Welsch; C Sommer; M Schiltenwolf; W Häuser
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

Review 7.  [Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].

Authors:  R Schaefert; P Welsch; P Klose; C Sommer; F Petzke; W Häuser
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

Review 8.  Opioids for neuropathic pain.

Authors:  Ewan D McNicol; Ayelet Midbari; Elon Eisenberg
Journal:  Cochrane Database Syst Rev       Date:  2013-08-29

Review 9.  Opioids compared to placebo or other treatments for chronic low-back pain.

Authors:  Luis Enrique Chaparro; Andrea D Furlan; Amol Deshpande; Angela Mailis-Gagnon; Steven Atlas; Dennis C Turk
Journal:  Cochrane Database Syst Rev       Date:  2013-08-27

10.  [S3 guideline LONTS. Long-term administration of opioids for non-tumor pain].

Authors:  H Reinecke; H Sorgatz
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

View more
  10 in total

1.  [Methodology report of the 2017 guidelines on fibromyalgia syndrome].

Authors:  W Häuser; M Nothacker
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

2.  Long-term opioid use in non-cancer pain.

Authors:  Winfried Häuser; Fritjof Bock; Peter Engeser; Thomas Tölle; Anne Willweber-Strumpfe; Frank Petzke
Journal:  Dtsch Arztebl Int       Date:  2014-10-24       Impact factor: 5.594

Review 3.  [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].

Authors:  M S Volz; B Siegmund; W Häuser
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

Review 4.  Mirtazapine for fibromyalgia in adults.

Authors:  Patrick Welsch; Kathrin Bernardy; Sheena Derry; R Andrew Moore; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2018-08-06

Review 5.  Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials.

Authors:  M-A Fitzcharles; C Baerwald; J Ablin; W Häuser
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

Review 6.  Cannabinoids in Pain Management and Palliative Medicine.

Authors:  Winfried Häuser; Mary-Ann Fitzcharles; Lukas Radbruch; Frank Petzke
Journal:  Dtsch Arztebl Int       Date:  2017-09-22       Impact factor: 5.594

Review 7.  [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].

Authors:  F Petzke; E K Enax-Krumova; W Häuser
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

8.  European Pain Federation position paper on appropriate opioid use in chronic pain management.

Authors:  T O'Brien; L L Christrup; A M Drewes; M T Fallon; H G Kress; H J McQuay; G Mikus; B J Morlion; J Perez-Cajaraville; E Pogatzki-Zahn; G Varrassi; J C D Wells
Journal:  Eur J Pain       Date:  2017-01       Impact factor: 3.931

Review 9.  Antipsychotics for fibromyalgia in adults.

Authors:  Brian Walitt; Petra Klose; Nurcan Üçeyler; Tudor Phillips; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2016-06-02

Review 10.  Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.

Authors:  Patrick Welsch; Nurcan Üçeyler; Petra Klose; Brian Walitt; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2018-02-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.